Dublin, June 04, 2020 (GLOBE NEWSWIRE) -- The "Inferior Vena Cava (IVC) Filter Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The inferior vena cava filter market is expected to grow at a CAGR of over 10% during the period 2019-2025.
The study considers the present scenario of the inferior vena cava filters market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent companies operating in the market.
The global inferior vena cava filter market is to grow steadily during the forecast period. The growth can be attributed to the high prevalence of Pulmonary Embolism (PE) across the world. According to the WHO, the incidence of PE is between 0.75 and 2.69 per 1,000 individuals per year globally. Epidemiological studies reported that more than 1 million people in the US are affected by PE annually, with approximately 100,000-200,000 PE fatalities. The overall healthcare expenditure on PE is estimated to be over $1.5 billion per year in the US alone.
Key Questions Answered:
- What are the growth trends, opportunities, and restraints impacting the IVC filter market?
- What are some technological improvements in inferior vena cava filter and healthcare segment?
- What are the strategies of major competitors and their market shares in IVC filter market?
- How will the hospital segment growth be likely in the IVC filter market during the forecast period?
- What is the growth of North America market during the forecast period?
Factors such as the growth in the aging population, consumption of junk foods, and the growth in the smoking population, the rise in lifestyle-related diseases, including obesity are increasing the prevalence of PE at a steady rate. Hence, the growing demand for optional & retrievable IVC filters and the increasing availability of innovative approaches for placement/retrieval are expected to drive the growth of the global IVC filter market. Moreover, the development of advanced devices, including bioconvertible, convertible, and combination IVC filters and central venous catheters is another primary factor driving the uptake of IVC filters worldwide. However, frequent product recalls due to safety concerns, coupled with the stringent regulatory process, are hindering the growth prospect of the global IVC filter market.
This research report includes a detailed segmentation by product, end-user, and geography. The retrievable & optional IVC filters segment is accounted for major share of 65% in 2019. The RIVCF segment is growing significantly on account of the increasing preference for optional IVCFs as they provide flexibility to remove IVCFs depending on the patient's requirement of permanent prophylaxis. Their ease of insertion is encouraging physicians to adopt retrievable ones. However, these devices have higher device-related complications in the long term than permanent ones. Moreover, RIVCFs are more expensive than permanent ones while reimbursement is the same for both.
In 2019, hospitals end-user segment accounted for 84% share of the global IVC filter market. Healthcare professionals in hospitals use advanced IVC filters such as retrievable/optional ones. The segment is growing at a healthy rate and is likely to grow at the same pace during the forecast period. The growth is primarily due to the high adoption of advanced filters, as a majority of patients with high-risk cardiac diseases prefer visiting hospitals for treatment due to advanced infrastructure facilities available in major private and public hospitals. Surgeons prefer to use advanced technology MRI- compatible, bioconvertible filters due to their high success rates and improved patient outcomes. Though hospitals have a greater number of IVC filter placements, the preference among patients to undergo implantation is increasing, thereby expecting healthy growth rates during the forecast period.
In 2019, North America accounted for 44% share of the global IVC filter market. The region is likely to witness an absolute growth of around 80% during the forecast period. The US is the major revenue contributor to the North America market and accounted for a share of 94% in 2019. The North American inferior vena cava filter market has become strategically important for several prominent players such as Cardinal Health, BD, Cook Medical and others. The market in this region is characterized by its high penetration of advanced treatment solutions for several vascular diseases due to the aging population and advances in technology.
Europe is the second largest market for vena cava filters. It is growing at a healthy rate and is expected to grow at a similar pace during the forecast period. The increasing incidence of PE, mainly in the growing aging population, rapid adoption of advanced vena cava filters and high healthcare expenditures are driving growth in Europe. It is estimated that more than 15% of the population in Europe is aged 65 years and above. The region is projected to remain the most aged one in the coming decades, with approximately 34% of the population projected to be aged 60 years or over in 2050. Hence, such a geriatric population is at a high risk of developing cardiac diseases, which leads to an increasing demand for vena cava filters in the region.
The APAC inferior vena cava filter market is growing at a significant healthy rate. The growth is due to the presence of a large pool of patient population, improvements in healthcare infrastructure, and increased healthcare expenditure. APAC serves as an attractive market destination for many global and local vendors. The healthcare system is undergoing rapid transformations with favorable support from government organizations. Japan, Australia, and South Korea are the major revenue contributors to the inferior vena cava filter market. In addition, healthcare providers are focusing on providing advanced care to patients, thereby contributing a high demand for IVCFs.
Brazil, Mexico, and Argentina are the major revenue contributors in the region. Cardiac diseases including PE are the major cause of mortality in Latin America. The presence of a large pool of the patient population that requires IVC filters, increase in government initiatives and funding on healthcare, and improvements in healthcare infrastructure are the main factors driving the market growth.
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Pulmonary Embolism: Overview
8 Market Opportunities & Trends
8.1 Expanding Indications For IVC Filters
8.2 Emergence Of Advanced/Innovative IVC Filters
8.3 Strategic M&As
9 Market Growth Enablers
9.1 Increasing Incidence Of Pulmonary Embolism
9.2 Innovative Approaches For IVC Filter Placements/Retrievals
9.3 High Demand For Retrievable IVC Filters
9.4 Rapid Technological Advancements
10 Market Restraints
10.1 Risks & Complications Associated With IVCFs
10.2 Product Recalls Due To Safety Concerns
10.3 High Cost Of IVCFs
10.4 Introduction Of Stringent Regulations
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
12 By Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
13 Retrievable & Optional IVC Filters
13.1 Market Overview
13.2 Market Size & Forecast
13.3 Retrievable & Optional IVC Filters By Geography
14 Permanent IVC Filters
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Permanent IVC Filters: Geography Segment
15 By End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.4 ASCs
15.5 Office-Based Labs
16 By Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 North America: Product Segmentation
17.4 Key Countries
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Europe: Product Segmentation
18.4 Key Countries
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 APAC: Product Segmentation
19.4 Key Countries
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Latin America: Product Segmentation
20.4 Key Countries
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Middle East & Africa: Product Segmentation
21.4 Key Countries
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
23 Key Company Profiles
23.1 Cardinal Health
23.2 BD
23.3 Cook Medical
23.4 B. Braun Melsungen
23.5 Boston Scientific
24 Other Prominent Vendors
24.1 ALN
24.2 Argon Medical Devices
24.3 Braile Biomdica
24.4 Lifetech Scientific
24.5 Mermaid Medical
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 By Product
26.2 By End-User
26.3 By Geography
26.4 North America: Product Segmentation
26.5 Europe: Product Segmentation
26.6 APAC: Product Segmentation
26.7 Latin America: Product Segmentation
26.8 MEA: Product Segmentation
26.9 Retrievable & Optional IVC Filters: Geographical Segmentation
26.1 Permanent IVC Filters: Geographical Segmentation
27 Appendix
27.1 Abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/vsf0op
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.